Chang Le, Shrestha Swati, LaChaud Greg, Scott Michelle A, James Aaron W
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Ave., 13-145 CHS, Los Angeles, CA, 90095, USA.
Med Oncol. 2015 Jun;32(6):613. doi: 10.1007/s12032-015-0613-z. Epub 2015 Apr 26.
MicroRNAs (miRNAs) are small noncoding RNAs, which play a complex role in posttranscriptional gene expression and can theoretically be used as a diagnostic or prognostic tool, or therapeutic target for neoplasia. Despite advances in the diagnosis and treatment of skeletal sarcomas, including osteosarcoma and chondrosarcoma, much remains unknown regarding their underpinning molecular mechanisms. Given the recent increasing knowledge base of miRNA roles in neoplasia, both as oncogenes and tumor suppressor genes, this review will focus on the available literature regarding the expression profiles and potential roles of miRNA in skeletal sarcomas. Although this is an emerging field, miRNA profiling may be of use in clarifying competing diagnoses of skeletal sarcomas and possibly indicate patient risk of resistance to traditional chemotherapeutic agents. While detecting and targeting miRNAs is currently limited to experimental investigations, miRNA may be utilized for future clinical management of skeletal sarcomas.
微小RNA(miRNA)是一类小的非编码RNA,其在转录后基因表达中发挥复杂作用,理论上可作为肿瘤的诊断、预后工具或治疗靶点。尽管在骨肉瘤和软骨肉瘤等骨骼肉瘤的诊断和治疗方面取得了进展,但关于其潜在分子机制仍有许多未知之处。鉴于最近关于miRNA在肿瘤中作为癌基因和肿瘤抑制基因作用的知识基础不断增加,本综述将聚焦于有关miRNA在骨骼肉瘤中的表达谱及潜在作用的现有文献。虽然这是一个新兴领域,但miRNA分析可能有助于明确骨骼肉瘤的鉴别诊断,并可能提示患者对传统化疗药物耐药的风险。虽然目前检测和靶向miRNA仅限于实验研究,但miRNA可能用于骨骼肉瘤未来的临床管理。